Robert Cooper, MD
Geriatric Medicine · Baltimore, MDNPI 1235159898
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,774 of the $6,746 with a category attached, or 85.6%. It is spread thinly across 38 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Among geriatric medicine clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 310 payments — averaging $21.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$814
- Novo Nordisk$808
- Lilly USA, LLC$729
- AstraZeneca$676
- Astellas Pharma US Inc$394
- Pfizer$361
- plus $3K from 32 others
What the payments were for
- Speaking & faculty fees$391%
- Travel & lodging$65810%
- Food & beverage$5,77486%
- Education$2754%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 4 | $814 |
| Novo Nordisk | 50 | $808 |
| Lilly USA, LLC | 44 | $729 |
| AstraZeneca(2 entities) | 43 | $676 |
| Astellas Pharma US Inc | 12 | $394 |
| Pfizer | 21 | $361 |
| Boehringer Ingelheim | 16 | $357 |
| AbbVie(2 entities) | 15 | $352 |
| Sanofi-aventis U.S. LLC | 16 | $323 |
| Merck | 17 | $309 |
| Sanofi | 5 | $269 |
| Amarin Pharma, Inc. | 9 | $206 |
| GSK | 10 | $179 |
| Amgen | 8 | $162 |
| Eisai Inc. | 5 | $103 |
| E.r. Squibb & Sons, L.L.C. | 1 | $96 |
| Exact Sciences | 3 | $81 |
| Bayer | 3 | $63 |
| Novartis | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Acorda Therapeutics, Inc | 2 | $39 |
| Shire North American Group Inc | 2 | $37 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Sanofi Pasteur Inc. | 2 | $24 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Tanabe Pharma America, Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $20 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Biogen | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $16 |
| Smith+Nephew | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMS 700 CXR RTE KIT$658
- AMS 700$107
How this compares
$6,746 in reported general payments places this provider in the 90th percentile of 112 geriatric medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 137 | $122,452 |
| FarxigaDapagliflozin Propanediol | 64 | $69,773 |
| JardianceEmpagliflozin | 45 | $56,916 |
| OzempicSemaglutide | 52 | $48,834 |
| XareltoRivaroxaban | 29 | $37,837 |
| JanuviaSitagliptin Phosphate | 21 | $33,074 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $18,417 |
| MyrbetriqMirabegron | 24 | $16,314 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 67 | $14,534 |
| MounjaroTirzepatide | 13 | $12,085 |
| Breo ElliptaFluticasone/Vilanterol | 26 | $11,376 |
| LinzessLinaclotide | 13 | $10,599 |
| Atorvastatin Calcium | 591 | $7,331 |
| Novolog FlexpenInsulin Aspart | 14 | $5,141 |
| Losartan Potassium | 352 | $4,353 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $361 | $125,311148 claims |
| AstraZenecaFarxiga | $676 | $69,77364 claims |
| Boehringer IngelheimJardiance | $357 | $56,91645 claims |
| Novo NordiskOzempic | $808 | $48,83452 claims |
| Johnson & JohnsonXarelto | $15 | $37,83729 claims |
| MerckJanuvia | $309 | $33,07421 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $179 | $29,79343 claims |
| Astellas Pharma US IncMyrbetriq | $394 | $16,31424 claims |
| AbbVieLinzess, Synthroid | $352 | $12,81864 claims |
| Lilly USA, LLCMounjaro | $729 | $12,08513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 112 geriatric medicine providers in Maryland.
Other geriatric medicine in Baltimore
- Sean LengBaltimore$412K
- Jocelyn El-SayedBaltimore$84K
- Bruce LeffBaltimore$7K
- Esther OhBaltimore$5K
- Neha KalariaBaltimore$4K
- Charmian SittambalamBaltimore$3K
- James RichardsonBaltimore$3K
- Dima HnooshBaltimore$2K
- Carla RosenthalBaltimore$864
- Kurupp DharmasenaBaltimore$829
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.